2-aryl substituted heterocyclic compounds as antiallgeric and anti-inflammatory agents

2-Aryl-substituierte heterocyclische Derivate als antiallergische und entzündunghemmende Mittel

Composés hétérocycliques substitués en 2 par un aryle comme agents antiallergiques et anti-inflammatoires

Abstract

Novel compounds having the formula and their pharmaceutically acceptable salts where R¹, R², R³, X, Y and Z have various meanings defined in the text are useful as anti-allergic and anti-inflammatory agents. Other novel 2-aryl substituted heterocyclic compounds are useful as chemical intermediates for the preparation of the compounds of formula I.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (4)

    Publication numberPublication dateAssigneeTitle
    EP-0219436-A2April 22, 1987Mitsubishi Kasei CorporationDérivés thiazoliques et antagoniste leucotrinique comprenant la même chose comme les ingrédients effectifs
    FR-2578540-A1September 12, 1986Leo Pharm Prod LtdNouveaux derives de pyridylmethoxy- et -methylmercaptoanilines, utilses notamment comme antiasthmatiques, leur fabrication et medicaments les contenant
    US-4581457-AApril 08, 1986American Home Products CorporationHeterocyclic sulfonamides
    US-4594425-AJune 10, 1986American Home Products CorporationHeterocyclic compounds as antiallergic agents

NO-Patent Citations (0)

    Title

Cited By (29)

    Publication numberPublication dateAssigneeTitle
    EP-0629624-A1December 21, 1994Takeda Chemical Industries, Ltd.Tetraderivate, ihre Herstellung und Verwendung
    EP-0906755-A2April 07, 1999Eli Lilly And CompanyVerwendung von Phenyloxazol oder Phenylthiazol Derivaten zur behandlung von neuropatischen Schmerzen
    EP-0906755-A3April 21, 1999Eli Lilly And CompanyUtilisation de dérivés phényloxazolés ou phénylthiazolés pour traiter les douleurs neuropathiques
    EP-0908180-A2April 14, 1999Eli Lilly And CompanyUtilisation de dérivés phénylthiazolés ou phényloxazolés pour traiter la douleur
    EP-0908180-A3April 21, 1999Eli Lilly And CompanyVerwendung von Phenyloxazol oder Phenylthiazol Derivaten zur Behandlung von Schmerzen
    EP-0908186-A2April 14, 1999Eli Lilly And CompanyMethod for treating pain
    EP-0908186-A3April 21, 1999Eli Lilly And CompanyMéthode de traitement de la douleur
    EP-0908454-A2April 14, 1999Eli Lilly And CompanyOxazole, Thiazole, Oxazoline, Oxadiazole und Benzoxazole und ihre Verwendung als nervenschützende Mittel
    EP-0908454-A3July 25, 2001Eli Lilly And CompanyOxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents
    EP-1578341-A2September 28, 2005Chemocentryx, Inc., Tularik Inc.Modulation de fonction de ccr4
    EP-1578341-A4September 28, 2005Tularik Inc, Chemocentryx IncModulation of ccr4 function
    EP-1723127-A4October 28, 2009Univ Ohio State Res Found, Univ Tennessee Res FoundationAnaloga, die die zellproliferation hemmen, verfahren zu deren herstellung und deren anwendung
    US-5340810-AAugust 23, 1994Glaxo Group LimitedBenzanilide derivatives
    US-5356893-AOctober 18, 1994Glaxo Group LimitedBenzanilide derivatives
    US-5358948-AOctober 25, 1994Glaxco Group LimitedBenzanilide derivatives
    US-5510350-AApril 23, 1996Glaxo Group LimitedBenzanilide derivatives
    US-5591862-AJanuary 07, 1997Takeda Chemical Industries, Ltd.Tetrazole derivatives, their production and use
    US-5639770-AJune 17, 1997Otsuka Pharmaceutical Co., Ltd.Thiazole derivatives
    US-5942530-AAugust 24, 1999Eli Lilly And CompanyMethod for treating pain
    US-5952360-ASeptember 14, 1999Eli Lilly And CompanyMethod for treating neuropathic pain
    US-6291487-B1September 18, 2001Otsuka Pharmaceutical Co., Ltd.Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
    US-6583163-B2June 24, 2003Otsuka Pharmaceutical Co., Ltd.Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
    US-7144903-B2December 05, 2006Amgen Inc.CCR4 antagonists
    US-7262204-B2August 28, 2007Amgen Inc., Chemocentryx, Inc.Modulation of CCR4 function
    US-7759357-B2July 20, 2010Novartis AgPhenylpyrimidine amines as IgE inhibitors
    US-8354439-B2January 15, 2013Otsuka Pharmaceutical Co., Ltd.Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
    WO-9106539-A1May 16, 1991American Home Products CorporationDerives d'acide phenylacetique 2-anilino utilises comme inhibiteurs de la phospholipase a2(pla2) et de la lipoxygenase
    WO-9324472-A1December 09, 1993Otsuka Pharmaceutical Co., Ltd.Thiazole derivative
    WO-9814191-A1April 09, 1998Otsuka Pharmaceutical Co., Ltd.Agent inhibant la production de cytokine et agent inhibant l'adhesion cellulaire